Neuralink races FDA approval for N1 brain implant

fortune.com9 min read

Brain-computer interface companies like Neuralink and Synchron are racing toward FDA approval for public sale, aiming to bring neural implants to market within the next few years. While current testing focuses on assisting patients with severe disabilities, developers anticipate broader commercial adoption and integration with AI. Experts and researchers also highlight growing concerns regarding mental privacy, workplace surveillance, and ethical governance as these technologies advance. Open article →